Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Colorcon
AstraZeneca
Mallinckrodt
Dow

Last Updated: June 25, 2022

Litigation Details for Andrulis Pharmaceuticals Corp. v. Celgene Corp. (D. Del. 2013)


✉ Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Andrulis Pharmaceuticals Corp. v. Celgene Corp.
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .
Biologic Drugs cited in Andrulis Pharmaceuticals Corp. v. Celgene Corp.

Details for Andrulis Pharmaceuticals Corp. v. Celgene Corp. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-10-02 1 the 22 Celgene-owned patents identified above, such as U.S. Patent Nos. 7,230,012 and 7,723,361, which…the 22 Celgene-owned patents identified above, such as U.S. Patent Nos. 7,230,012 and 7,723,361, which… 7,230,012 7,323,479 … The Patent in Suit 9. U.S. Patent No. 6,140,346 (β€œthe ’346 patent”), entitled β€œ… 1. This action alleges patent infringement under the patent laws of the United States, Title External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Boehringer Ingelheim
AstraZeneca
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.